Sharon Peleg Nesher, Mijal Luria, Gideon Sartorius, Francesca Tripodi, Michal Lew-Starowicz, Stephanie Both, Elisa Maseroli, Yacov Reisman, Giovanni Corona
{"title":"Clinical practice guidelines: sexual dysfunction in gynecological cancer patients.","authors":"Sharon Peleg Nesher, Mijal Luria, Gideon Sartorius, Francesca Tripodi, Michal Lew-Starowicz, Stephanie Both, Elisa Maseroli, Yacov Reisman, Giovanni Corona","doi":"10.1093/sexmed/qfaf0066","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sexual dysfunctions (SDs) due to gynecological cancer (GC) are common. Healthcare providers (HCPs) are often not prepared to address sexual health issues, missing the opportunity to provide comprehensive post-cancer survivorship care.</p><p><strong>Aim: </strong>To review the available evidence about diagnosing and managing SD after GC and providing practical clinical suggestions on behalf of the European Society of Sexual Medicine.</p><p><strong>Methods: </strong>A systematic literature search was performed on Pubmed and Medline for the relevant literature from January 1980 until June 2024.</p><p><strong>Outcomes: </strong>Recommendations were provided according to the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence criteria, focusing on clinical practice.</p><p><strong>Results: </strong>The main areas covered include the impact of diagnosis and treatment of GC (surgery, chemotherapy, immunotherapy, and radiotherapy) on sexual health; the process of screening, counseling, and referral; medical and psychological management of SD; issues related to special populations, ie, sexual minorities and previvors.</p><p><strong>Clinical implications: </strong>Addressing aspects of sexual health is important in patients with GC during diagnosis, treatment, and post-cancer care. Diagnosis and treatment of SDs should follow the recommendations in non-cancer patients, but specific aspects linked to cancer and its treatment should be kept in mind.</p><p><strong>Strengths and limitations: </strong>All studies have been evaluated by a panel of experts who provide comprehensive, evidence-based recommendations for clinical practice.</p><p><strong>Conclusion: </strong>HCPs should feel comfortable addressing sexual health topics in patients with GCs due to the abundance of available data. Appropriate sexological interventions can improve the quality of life for patients and their partners.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 4","pages":"qfaf066"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401004/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sexmed/qfaf0066","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Sexual dysfunctions (SDs) due to gynecological cancer (GC) are common. Healthcare providers (HCPs) are often not prepared to address sexual health issues, missing the opportunity to provide comprehensive post-cancer survivorship care.
Aim: To review the available evidence about diagnosing and managing SD after GC and providing practical clinical suggestions on behalf of the European Society of Sexual Medicine.
Methods: A systematic literature search was performed on Pubmed and Medline for the relevant literature from January 1980 until June 2024.
Outcomes: Recommendations were provided according to the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence criteria, focusing on clinical practice.
Results: The main areas covered include the impact of diagnosis and treatment of GC (surgery, chemotherapy, immunotherapy, and radiotherapy) on sexual health; the process of screening, counseling, and referral; medical and psychological management of SD; issues related to special populations, ie, sexual minorities and previvors.
Clinical implications: Addressing aspects of sexual health is important in patients with GC during diagnosis, treatment, and post-cancer care. Diagnosis and treatment of SDs should follow the recommendations in non-cancer patients, but specific aspects linked to cancer and its treatment should be kept in mind.
Strengths and limitations: All studies have been evaluated by a panel of experts who provide comprehensive, evidence-based recommendations for clinical practice.
Conclusion: HCPs should feel comfortable addressing sexual health topics in patients with GCs due to the abundance of available data. Appropriate sexological interventions can improve the quality of life for patients and their partners.
期刊介绍：
Sexual Medicine is an official publication of the International Society for Sexual Medicine, and serves the field as the peer-reviewed, open access journal for rapid dissemination of multidisciplinary clinical and basic research in all areas of global sexual medicine, and particularly acts as a venue for topics of regional or sub-specialty interest. The journal is focused on issues in clinical medicine and epidemiology but also publishes basic science papers with particular relevance to specific populations. Sexual Medicine offers clinicians and researchers a rapid route to publication and the opportunity to publish in a broadly distributed and highly visible global forum. The journal publishes high quality articles from all over the world and actively seeks submissions from countries with expanding sexual medicine communities. Sexual Medicine relies on the same expert panel of editors and reviewers as The Journal of Sexual Medicine and Sexual Medicine Reviews.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
